CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Diabetes Assistant (DiAs) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01973413
NCT01973413N/ACompleted
CompareCT.gov

Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study

University of Virginia·interventional·Posted Oct 31, 2013·Updated Apr 24, 2015

In Brief

A clinical study evaluating Diabetes Assistant (DiAs), Tandem t:slim Insulin Pump, and 1 other intervention for Diabetes Mellitus, Type 1. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The primary goal is to test the function of the Diabetes Assistant (DiAs) enhanced control-to-range (CTR) controller in a closely monitored diabetes camp setting. The camp setting will allow us to obtain pilot efficacy data.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
CollaboratorsStanford University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 31, 2013
Enrollment StartJul 1, 2013
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.7 years ago

Interventions

Diabetes Assistant (DiAs)device

The Control-to-Range (CTR) algorithm that will be used in DiAs will automatically adjusts insulin delivery in response to CGM values that have exceeded or are predicted to exceed the bounds of a pre-specified blood glucose range.

Tandem t:slim Insulin Pumpdevice

FDA, market-approved insulin pump.

Dexcom G4 Platinum sensordevice

FDA, market-approved continuous glucose monitor (CGM)